Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer.
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer. — المؤلف: Wong, Matthew K — Cancer chemotherapy and pharmacology 20100503
- المؤلف
- Wong, Matthew K
- النشر
- Cancer chemotherapy and pharmacology 20100503
- الوصف
- 1023-8 p.
- الموضوعات
- Aged؛ Aged, 80 and over؛ Carcinoma, Non-Small-Cell Lung؛ Erlotinib Hydrochloride؛ Female؛ Gefitinib؛ Humans؛ Kaplan-Meier Estimate